Clinical Trial Update: Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravesical Lactobacillus to reduce urinary symptoms in spinal cord injury with neurogenic bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Spinal Cord Injury

Drugs mentioned

• Intravesical Lactobacillus (Lactobacillus)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Spinal Cord Injuries, Neurogenic Bladder | Phase 2 | Status: COMPLETED